أرسل هذا في رسالة قصيرة: Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

 ______    __   __   _    _     _____    _____    
|      \\  \ \\/ // | \  / ||  |  ___|| |  __ \\  
|  --  //   \ ` //  |  \/  ||  | ||__   | |  \ || 
|  --  \\    | ||   | .  . ||  | ||__   | |__/ || 
|______//    |_||   |_|\/|_||  |_____|| |_____//  
`------`     `-`'   `-`  `-`   `-----`   -----`